Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@jax.org
Therapy Name | SPP86 |
Synonyms | |
Therapy Description |
SPP86 is a multi-kinase inhibitor with activity against RET, EPHA1, FGFR1, FGFR2, FLT4, LCK, and YES, which may reduce proliferation and induce apoptosis in cancer cells (PMID: 25409876). |
Drug Name | Trade Name | Synonyms | Drug Classes | Drug Description |
---|---|---|---|---|
SPP86 | FGFR1 Inhibitor 28 FGFR2 Inhibitor 23 LCK Inhibitor 6 RET Inhibitor 52 YES Inhibitor 3 | SPP86 is a multi-kinase inhibitor with activity against RET, EPHA1, FGFR1, FGFR2, FLT4, LCK, and YES, which may reduce proliferation and induce apoptosis in cancer cells (PMID: 25409876). |
Molecular Profile | Indication/Tumor Type | Response Type | Therapy Name | Approval Status | Evidence Type | Efficacy Evidence | References |
---|
Clinical Trial | Phase | Therapies | Title | Recruitment Status | Covered Countries | Other Countries |
---|